Epidemiology articles for National Institutes of Health (NIH), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 25

Article ‘Count’ for Epidemiology.

Journal Count Share
1 0.31
The 2018 World Cancer Research Fund /American Institute for Cancer Research Score and Cancer Risk: Results from the Diabetes Prevention Program Outcomes Study 0.31
1 0.25
Active surveillance of cervical intraepithelial neoplasia grade 2 is not associated with an increased risk of non-cervical anogenital HPV-related cancer and precancer a population-based cohort study 0.25
1 1.00
Carcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000 Americans 1.00
3 0.46
Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications. 0.14
Trends in Cancer Incidence in Younger and Older Adults : An International Comparative Analysis. 0.22
Screening for Anal Cancer Among Men Who Have Sex With Men With HIV: Benefits, Harms, and Cost-Effectiveness Analyses. 0.10
1 0.50
Ambient air pollution in critical windows of exposure and spontaneous miscarriage in a preconception cohort 0.50
1 0.09
Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction 0.09
1 0.38
Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping. 0.38
3 1.18
Risk-based prophylactic HPV vaccination of heterosexual US men aged 27 to 45 years for prevention of oropharyngeal cancer 0.67
IPVS Consensus Statement on the Natural History of Cervical HPV Infection 0.08
Validation of TypeSeq2, a Next-Generation–Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories 0.43
1 0.03
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050 0.03
6 2.68
State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras 0.14
Cervical cancer incidence rates by birth cohort against the backdrop of human papillomavirus vaccination in the United States 0.25
Impact of repeatedly screening negative on cervical cancer risk 0.43
U.S. cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019 0.86
Spectrum of cancer risk in Asian American and Pacific Islander solid organ transplant recipients 0.50
Impact of screening for human papillomavirus-positive oropharyngeal cancers: a microsimulation-based modeling study 0.50
2 0.09
Age-specific clinical performance of HPV-based vs. cytology-based cervical cancer screening in China 0.03
One-hour extraction-free loop-mediated isothermal amplification HPV DNA assay for point-of-care testing in Maputo, Mozambique 0.06
1 0.13
Reconstructing the early spatial spread of pandemic respiratory viruses in the United States 0.13
1 0.50
Spatio-temporal spread of COVID-19 over three variant waves in the continental United States 0.50
1 0.00
The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 0.00
1 0.09
Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types 0.09

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.